MedTrace Logo

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

NCT01004640 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-09-14

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and bone marrow from patients with cancer may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood and bone marrow samples in patients with chronic myelogenous leukemia enrolled on a CALGB clinical trial.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

Southern blotting

GENETIC

cytogenetic analysis

Correlative studies

GENETIC

polymerase chain reaction

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Wendy Stock, MD · University of Chicago

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-12-15
Primary Completion
2001-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01004640 on ClinicalTrials.gov